Logo

People in the News: Olivier Pasquier

Mar 20, 2013
Premium

French cell chip company Cytoo has named Olivier Pasquier as its chief commercial officer. Pasquier was Qiagen's senior marketing manager in Europe before joining Cytoo. He holds an MBA from ESCP Europe and a degree in molecular biology from the French University Nice-Sophia Antipolis. In his new role at Cytoo, Pasquier will be responsible for the continued sales of the company's 2D+ Cell Culture Platform as well as developing new markets in cell-based assays and screening.

Filed under

Microarrays & Multiplexing
microarrays
Cytoo
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.